Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-022828
Filing Date
2010-03-10
Accepted
2010-03-10 07:00:29
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K b78700e10vk.htm 10-K 1134483
2 EX-10.15 b78700exv10w15.htm EX-10.15 5142
3 EX-23.1 b78700exv23w1.htm EX-23.1 1726
4 EX-31.1 b78700exv31w1.htm EX-31.1 8204
5 EX-31.2 b78700exv31w2.htm EX-31.2 8224
6 EX-32.1 b78700exv32w1.htm EX-32.1 3043
7 EX-32.2 b78700exv32w2.htm EX-32.2 3067
8 GRAPHIC b78700b7870001.gif GRAPHIC 9904
  Complete submission text file 0000950123-10-022828.txt   1179180
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31918 | Film No.: 10668821
SIC: 2836 Biological Products, (No Diagnostic Substances)